Investors / United States / Morgenthaler Ventures
Morgenthaler Ventures
Venture capital · Portola Valley, CA, United States · North America
Morgenthaler Ventures is a venture capital and private equity firm that has been operating for more than 40 years. Its life science team continues to manage life science companies across all active Morgenthaler funds, and in 2012 certain members of the Morgenthaler and Advanced Technology Ventures life science teams formed the separate entity Lightstone Ventures.
Invests inHealthcare & Biotech
In its own wordslife sciencesmedical devicesbiopharmaceuticalsinformation technologyprivate equity
Your fit with Morgenthaler Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsMorgenthaler Ventures lists 14 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series B, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (43%), AI & Machine Learning (14%) and Developer Tools (10%). 78% of its companies are based in United States. It invests most often alongside NEA, Asahi Kasei Ventures and Asset Management Company.
Counts come from funding rounds that name Morgenthaler Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Morgenthaler Ventures' whole history. Rounds on record name 1 company; its own site lists 14. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundMorgenthaler Ventures does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 100% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 36th | 14 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 77th | 43% in its largest sector |
| Reach | 58th | 3 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 43% | 15% |
| AI & Machine Learning | 14% | 18% |
| Developer Tools | 10% | 0% |
| Cybersecurity | 10% | 4% |
| Industrial & Manufacturing | 5% | 7% |
| Fintech | 5% | 12% |
| Space & Defense | 5% | 3% |
| Consumer | 5% | 3% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| NEA | 2 |
| Asahi Kasei Ventures | 1 |
| Asset Management Company | 1 |
| Canvas Ventures | 1 |
| Catalio Capital Management | 1 |
| Citta Capital | 1 |
| Elevage Medical Technologies | 1 |
| Emergence Capital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers14100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare Morgenthaler Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Morgenthaler Ventures| Date | Company | Stage |
|---|---|---|
| 11 Aug 2025 | Series B |
Round details for Morgenthaler Ventures
Amounts, full round histories and every co-investor in Morgenthaler Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
14 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company sells various electronic devices and offers entertainment services. | ConsumerEnterprise Software | Portfolio page | ||
| Atria Software provides design, development, and support for custom software solutions for businesses across various industries. | Space & DefenseHealthcare & Biotech | Portfolio page | ||
| Doximity provides AI-powered tools and resources for doctors and clinicians, including clinical answers, charting, and communication services. | Healthcare & Biotech | Portfolio page | ||
| GlobeImmune is developing Tarmogen product candidates to treat cancer and infectious diseases. | Healthcare & Biotech | Portfolio page | ||
| Hypres develops and commercializes ultra-high-speed superconductor integrated circuits and energy-efficient cryogenic systems | AI & Machine LearningCybersecurity | Portfolio page | ||
| Nuance provides speech recognition solutions and AI-powered solutions for healthcare | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| NuoDB enables enterprise-grade applications to run in any cloud, delivering continuous availability and dynamic scale out/in based on usage demands | Developer ToolsDeveloper Tools | Portfolio page | ||
| Nuvaira develops a one-time COPD treatment to preserve lung health. | Healthcare & Biotech | Portfolio page | ||
| Olympic Ophthalmics develops and distributes a medical device to help people produce more of their own tears | Healthcare & Biotech | Portfolio page | ||
| QuickLogic designs and develops specialized FPGA devices and user tools, including eFPGA IP and custom FPGA chiplets | AI & Machine LearningCybersecurity | Portfolio page | ||
| R2 Semiconductor is a power management company whose industry-changing IP serves market needs ranging from low-power wearables to high-performance network processors, and offers efficient, high voltage power via low voltage transistors. | Industrial & Manufacturing | Portfolio page | ||
| SetPoint Medical develops a device-based therapeutic approach for treating rheumatoid arthritis | Healthcare & Biotech | Aug 2025Series B | Funding round | |
| Spine Wave develops and delivers innovative technologies to assist physicians in treating spinal disorders and improving patients' lives | Healthcare & Biotech | Portfolio page | ||
| The company helps organizations navigate change and achieve their goals by providing various services such as leadership development, innovation, and talent management | Healthcare & BiotechFintech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- morgenthaler.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 11 Aug 2025
- Companies checked
- 14
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Morgenthaler Ventures' profile as data
Pull Morgenthaler Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/morgenthaler.com
# also
GET /v1/firms/morgenthaler.com/portfolio
GET /v1/firms/morgenthaler.com/coinvestors
GET /v1/firms/morgenthaler.com/news